STERIS AST expands laboratory services offering

STERIS Applied Sterilization Technologies (AST) is pleased to announce we have expanded our laboratory services offering with the addition of product validation and testing, package validation and testing, and technical support services. A critical piece of new product development, these services ensure that medical devices perform as expected for the life of the product, while the packaging maintains the sterility of the device until its point of use.

In conjunction with the microbial validation services provided by STERIS Laboratories, the product and packaging services provide a comprehensive portfolio of testing options for the validation of sterile medical devices.  Product release to market is further supported by the STERIS AST global network of contract sterilization facilities.

The expanded service offering furthers STERIS’s commitment to providing Customers with a comprehensive offering of medical device testing and technology-neutral contract sterilization services. We are excited to offer packaging and product testing, microbial and analytical testing, and technical support services throughout our global STERIS Laboratories network.

STERIS AST is also expanding existing sterilization and laboratory services capacity at its Tullamore, Ireland site.  The facility is in the process of constructing a new laboratory, in addition to the installation of a second E-beam facility, the introduction of vaporized hydrogen peroxide (VHP) processing capability, and the addition of extra ethylene oxide processing capacity.

The addition of the product and packaging testing services, combined with the expansion activities at the STERIS Tullamore site, demonstrate our commitment to the Irish Medtech community and providing both global and local Customers with comprehensive sterilization and laboratory services options.
Anecto-Image

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. 

WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services. 

For more information, visit www.steris.com.

 
Related Posts
STERIS Venlo, NL Facility
October 8, 2026
As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the completion of the expansion of its existing Venlo, The Netherlands ethylene oxide and X-ray processing facility to include a second X-ray processing line. 
STERIS Alajuela, Costa Rica
September 29, 2026

As part of our long-term commitment to supporting global medical device and pharmaceutical manufacturing, STERIS is pleased to announce the expansion of the laboratory testing capabilities available at our facility in Alajuela, Costa Rica.

STERIS Ede, The Netherlands Laboratory
September 28, 2026

As part of our long-term commitment to supporting global medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce that the Ede, The Netherlands laboratory has achieved ISO 17025 accreditation.

Montreal Opening Announcement
August 24, 2026

As part of our commitment to ensuring patient and consumer safety, STERIS is pleased to announce the competition of a new electron beam (E-beam) processing facility in Montreal, Canada.